Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Efficacy and Safety of Famciclovir 1-day Treatment Compared to 3-day Treatment With Valacyclovir in Adults With Recurrent Genital Herpes

ClinicalTrials.gov ID: NCT00306787

Public ClinicalTrials.gov record NCT00306787. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 23, 2026, 7:14 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multicenter, Randomized, Double-blind Study to Compare the Efficacy and Safety of Patient-initiated Famciclovir 1000 mg b.i.d. x 1 Day to Valacyclovir 500 mg b.i.d. x 3 Days in Immunocompetent Adults With Recurrent Genital Herpes

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This study will assess the safety and efficacy of one-day famciclovir (1000 mg twice a day (b.i.d)) in reducing the duration of genital herpes lesions and the associated symptoms compared to three-day treatment with valacyclovir (500 mg capsule b.i.d).

Study identification

NCT ID
NCT00306787
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Novartis Pharmaceuticals
Industry
Enrollment
1,179 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 2006 (Type not available)
Primary completion
Feb 2008 (Actual)
Completion
Feb 2008 (Actual)
Last update posted
Jun 30, 2011

2006 – 2008

United States locations

U.S. sites
51
U.S. states
25
U.S. cities
48
Facility City State ZIP Site status
University of Alabama at Birmingham Birmingham Alabama 35294 —
Novartis Investigative Site Chandler Arizona 85225 —
Women's Health Research Phoenix Arizona 85015 —
Quality of Life Medical & Research Center, LLC Tucson Arizona 85712 —
Burke Pharmaceutical Research Hot Springs Arkansas 71913 —
NEA Women's Clinic Jonesboro Arkansas 72401 —
The Woman's Clinic Little Rock Arkansas 72205 —
Providence Clinical Research Burbank California 91505 —
Dermatology Research Associates Los Angeles California 90045 —
Sacramento Research Medical Group Sacramento California 95825 —
North California Research Corp. Sacramento California 95831 —
Medical Center for Clinical Research San Diego California 92108 —
Conant Research San Francisco California 94114 —
Barbara Davis Center Denver Colorado 80262 —
Cohen & Womack, P.C. Lakewood Colorado 80228 —
Visions Clinical Research Boynton Beach Florida 33437 —
Women's Medical Research Group, LLC Clearwater Florida 33759 —
International Research Association LLC Miami Florida 33156 —
Orlando Clinical Research Ctr. Orlando Florida 32809 —
Avancia Research Pembroke Pines Florida 33024 —
University Clinical Research, Inc. Pembroke Pines Florida 33024 —
Palm Beach Research Center West Palm Beach Florida 33409 —
Mount Vernon Clinical Research Atlanta Georgia 30328 —
Medisphere Medical Research Center, LLC. Evansville Indiana 47714 —
Indiana University Infectious Disease Research Group Indianapolis Indiana 46202 —
Heartland Research Associates, LLC Wichita Kansas 67207 —
Common Wealth Biomedical Research Madisonville Kentucky 42431 —
SNBL Clinical Pharmacology Center Baltimore Maryland 21201 —
Future Care Studies Springfield Massachusetts 01107 —
Clayton Research Institute St Louis Missouri 63117 —
Deaconess Billings Clinic Research Center Billings Montana 59101 —
Heartland Clinical Research, Inc. Omaha Nebraska 68134 —
UNC Clinical Research. Raleigh North Carolina 27607 —
Hawthorne Medical Research, Inc. Winston-Salem North Carolina 27103 —
Providence Health Partners-Center for Clinical Research Dayton Ohio 45439 —
Lynne Health Science Institute Oklahoma City Oklahoma 73112 —
Westover Heights Clinic Portland Oregon 97210 —
Paddington Testing Co. Inc Philadelphia Pennsylvania 19103 —
Magee Womens Hospital Pittsburgh Pennsylvania 15213 —
S. Carolina Clinical Research Center Columbia South Carolina 29201 —
Research Inc. Florence South Carolina 29501 —
Palmetto Clinical Trial Services, LLC Simpsonville South Carolina 29681 —
Benchmark Research Austin Texas 78705 —
Renaissance Clinical Research and Hypertension Clinic Dallas Texas 75235 —
Center for Clinical Studies (TX Medical Center) Houston Texas 77030 —
Center for Clinical Studies Houston Texas 77058 —
University of Utah-School of Medicine (Div. of Inf. Disease) Salt Lake City Utah 84132 —
Salt Lake Women's Center/Physician's Research Options Sandy City Utah 84070 —
Clinical Trials of Virginia, Inc. Richmond Virginia 23225 —
University of Washington, Virology Research Clinic Seattle Washington 98122 —
Liberty Research Center Tacoma Washington 98405 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 15 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00306787, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 30, 2011 · Synced Oct 23, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00306787 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →